Korosho Approves 3 Switch OTC Products Containing Pemirolast

November 18, 2011
Korosho approved Mitsubishi Tanabe Pharma Corporation’s switch OTC drugs Alegysal Rhinitis, Alegysal OTC, and Alescape, all of which contain the anti-allergic agent pemirolast potassium, as new Class 1 OTC drugs on November 18. The three products are indicated for sneezing,...read more